GUARDANT HEALTH ($GH) posted quarterly earnings results on Wednesday, October 29th. The company reported earnings of -$0.39 per share, beating estimates of -$0.79 by $0.40. The company also reported revenue of $265,200,000, beating estimates of $242,762,296 by $22,437,704.
You can see Quiver Quantitative's $GH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GUARDANT HEALTH Insider Trading Activity
GUARDANT HEALTH insiders have traded $GH stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $GH stock by insiders over the last 6 months:
- HELMY ELTOUKHY (Co-Chief Executive Officer) has made 0 purchases and 2 sales selling 300,000 shares for an estimated $17,835,995.
- AMIRALI TALASAZ (Co-Chief Executive Officer) has made 0 purchases and 12 sales selling 340,000 shares for an estimated $16,998,565.
- IAN T CLARK sold 6,672 shares for an estimated $322,818
- KUMUD KALIA (Chief Information Officer) has made 0 purchases and 2 sales selling 6,000 shares for an estimated $309,071.
- MUSA TARIQ has made 0 purchases and 6 sales selling 3,793 shares for an estimated $190,248.
- MEGHAN V. JOYCE has made 0 purchases and 3 sales selling 3,537 shares for an estimated $168,323.
- MYRTLE S POTTER has made 0 purchases and 6 sales selling 2,756 shares for an estimated $137,773.
- MEDINA MANUEL HIDALGO sold 2,165 shares for an estimated $117,250
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GUARDANT HEALTH Hedge Fund Activity
We have seen 194 institutional investors add shares of GUARDANT HEALTH stock to their portfolio, and 160 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 1,625,148 shares (+148.2%) to their portfolio in Q2 2025, for an estimated $84,572,701
- CADIAN CAPITAL MANAGEMENT, LP removed 1,415,870 shares (-30.8%) from their portfolio in Q2 2025, for an estimated $73,681,874
- ARK INVESTMENT MANAGEMENT LLC added 1,414,381 shares (+100.4%) to their portfolio in Q2 2025, for an estimated $73,604,387
- SUMITOMO MITSUI TRUST GROUP, INC. removed 1,276,484 shares (-62.9%) from their portfolio in Q3 2025, for an estimated $79,754,720
- DEEP TRACK CAPITAL, LP removed 1,193,721 shares (-21.9%) from their portfolio in Q2 2025, for an estimated $62,121,240
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,136,068 shares (+180.5%) to their portfolio in Q2 2025, for an estimated $59,120,978
- UBS GROUP AG removed 1,097,242 shares (-48.1%) from their portfolio in Q2 2025, for an estimated $57,100,473
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GUARDANT HEALTH Analyst Ratings
Wall Street analysts have issued reports on $GH in the last several months. We have seen 16 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 10/22/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- Barclays issued a "Overweight" rating on 10/02/2025
- Canaccord Genuity issued a "Buy" rating on 09/26/2025
- BTIG issued a "Buy" rating on 09/25/2025
- TD Cowen issued a "Buy" rating on 09/25/2025
- Stifel issued a "Buy" rating on 09/25/2025
To track analyst ratings and price targets for GUARDANT HEALTH, check out Quiver Quantitative's $GH forecast page.
GUARDANT HEALTH Price Targets
Multiple analysts have issued price targets for $GH recently. We have seen 16 analysts offer price targets for $GH in the last 6 months, with a median target of $71.0.
Here are some recent targets:
- David Westenberg from Piper Sandler set a target price of $90.0 on 10/22/2025
- Daniel Markowitz from Evercore ISI Group set a target price of $68.0 on 10/07/2025
- Luke Sergott from Barclays set a target price of $70.0 on 10/02/2025
- Kyle Mikson from Canaccord Genuity set a target price of $75.0 on 09/26/2025
- Casey Woodring from JP Morgan set a target price of $70.0 on 09/25/2025
- Doug Schenkel from Wolfe Research set a target price of $75.0 on 09/25/2025
- Puneet Souda from Leerink Partners set a target price of $75.0 on 09/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
